|本期目录/Table of Contents|

[1]吴晶晶,马如超,闫波.冠心病与病原微生物感染相关性研究进展[J].慢性病学杂志,2018,(01):31-34.
点击复制

冠心病与病原微生物感染相关性研究进展(PDF)

《慢性病学杂志》[ISSN:1674-8166/CN:11-5900/R]

卷:
期数:
2018年01期
页码:
31-34
栏目:
综 述
出版日期:
2018-01-30

文章信息/Info

Title:
-
作者:
吴晶晶1马如超2闫波13
1.济宁医学院,山东 济宁 272000; 2.山东大学齐鲁医学院,济南 250012; 3.济宁医学院附属医院,山东 济宁 272000
Author(s):
-
关键词:
冠状动脉粥样硬化性心脏病动脉粥样硬化乙型肝炎病毒人巨细胞病毒单纯疱疹病毒人类免疫 缺陷病毒肺炎支原体
Keywords:
-
分类号:
R541.4
DOI:
-
摘要:
冠心病是一种常见的并严重影响人类健康的疾病。病原微生物感染对冠心病的发生发展起着重要的影响。 病原微生物感染可直接通过炎症反应,或激活机体的免疫系统促进动脉粥样斑块的形成,最终导致冠心病等心血 管疾病的发生、发展。目前,随着对病原微生物的认识和其对相关疾病发病机制的研究,发现病原微生物感染是冠 心病发病的危险因素之一。因而对病原微生物的早期认识、发现、干预,将有效的降低冠心病的发病率和病死率。
Abstract:
-

参考文献/References:

[1] Watkins DA, Johnson CO, Colquhoun SM,et al. Global, Regional, and National Burden of Rheumatic Heart Dis-ease, 1990-2015 [J]. N Engl J Med, 2017,377(8):713-722.
[2] Munro HM, Tarone RE, Wang TJ,et al. Menthol and Nonmenthol Cigarette Smoking: All- Cause Deaths, Car-diovascular Disease Deaths, and Other Causes of Death Among Blacks and Whites [J]. Circulation,2016,133(19): 1861-1866.
[3] Ray KK, Landmesser U, Leiter LA,et al. Inclisiran in Patients at High Cardiovascular Risk with Elevated LDL Cholesterol [J]. N Engl J Med,2017,376(15):1430-1440.
[4] Williamson JD, Supiano MA, Applegate WB,et al. In-tensive vs Standard Blood Pressure Control and Cardiovas-cular Disease Outcomes in Adults Aged ≥75 Years: A Randomized Clinical Trial [J]. JAMA,2016,315(24):2673-2682.
[5] Mente A, O'Donnell M, Rangarajan S,et al. Associations of urinary sodium excretion with cardiovascular events in individuals with and without hypertension: a pooled analy-sis of data from four studies [J]. The Lancet, 2016,388 (10043):465-475.
[6] Khera AV, Emdin CA, Drake I,et al. Genetic Risk, Ad-herence to a Healthy Lifestyle, and Coronary Disease [J]. N Engl J Med,2016,375(24):2349-2358.
[7] Wang C, Zhao P, Luo P,et al. Prevalence and risk fac-tors of coronary artery disease in patients with chronic vi-ral hepatitis [J]. Postgraduate Medicine, 2015,127(8):786-790.
[8] Sorlie PD, Nieto FJ, Adam E,et al. A prospective study of cytomegalovirus, herpes simplex virus 1, and coronary heart disease: the atherosclerosis risk in communities (AR-IC) study [J]. Arch Intern Med, 2000,160(13):2027-2032.
[9] Lin YJ, Gutierrez J, Albuquerque ALA,et al. HIV infec-tion as vascular risk: A systematic review of the literature and meta-analysis [J]. PLoS One, 2017,12(5):e0176686.
[10] Momiyama Y, Ohmori R, Taniguchi H,et al. Associa-tion of Mycoplasma pneumoniae infection with coronary ar-tery disease and its interaction with chlamydial infection [J]. Atherosclerosis, 2004,176(1):139-144.
[11] 王贵强,王福生,成军,等.慢性乙型肝炎防治指南(2015更新版) [J].临床肝胆病杂志,2015,31(12):1941-1960.
[12] Li JJ, Li YS, Fang CH, et al. Effects of simvastatin within two weeks on anti-inflammatory cytokine interleu-kin 10 in patients with unstable angina [J]. Heart, 2006,92 (4):529-530.
[13] 马玉龙,李晓梅,杨毅宁,等.乙型肝炎病毒感染与冠心病的关联 性分析[J].中国动脉硬化杂志,2014,22(10):1035-1038.
[14] Kuo CS, Chen YT, Hsu CY,et al. The impact of chron-ic hepatitis B infection on major adverse cardiovascular events and all-cause mortality in patients with diabetes: a nationwide population-based study from Taiwan [J]. BMJOpen,2017,7(8):e016179.
[15] Aiolfi R, Sitia G. Chronic hepatitis B: role of anti-platelet therapy in inflammation control [J]. Cell Mol Immunol, 2015,12(3):264-268.
[16] Hao S, Wang Y, Gao G,et al. Hepatitis B Virus Upreg-ulates the Expression of C-reactive Protein Both in vivo and in vitro [J]. Annals of Clinical & Laboratory Science, 2017,47(4):432-435.
[17] Trehanpati N, Vyas AK. Immune Regulation by T Regu-latory Cells in Hepatitis B Virus- Related Inflammation and Cancer [J]. Scand J Immunol, 2017,85(3):175-181.
[18] Li WC, Lee YY, Chen IC, et al. Association between the hepatitis B and C viruses and metabolic diseases in pa-tients stratified by age [J]. Liver Int, 2013,33(8):1194-1202.
[19] 吴正浩,陈捷.人巨细胞病毒感染对老年冠心病患者冠状动脉病 变程度及Ghrelin/Obestatin的影响[J].山东医药,2016,56(44): 46-47.
[20] 杜立平,朱淑芬.冠心病患者动脉粥样硬化与人巨细胞病毒检测 结果的相关性分析[J].标记免疫分析与临床,2016,23(12):1379-1381.
[21] 刘大男,李金生,刘兴德,等.巨细胞病毒感染与冠心病急性心肌 梗死的相关性研究[J].中国老年学杂志,2009,2(29):203-205.
[22] 韩卫红,李国良,王淑霞. HCMV感染与动脉粥样硬化及急性冠 脉综合征的相关性研究进展[J].河北医药,2011,33(13):2027-2029.
[23] Huang ZR, Yu LP, Yang XC,et al. Human cytomegalo-virus linked to stroke in a Chinese population [J]. CNS Neurosci Ther,2012,18(6):457-460.
[24] 姚磊,晏玲,罗福康,等.冠心病患者外周血单个核细胞HCMV-DNA的荧光定量PCR检测[J].中国病原生物学杂志,2011,6(8): 571-573.
[25] 潘思争,叶秀玲,王玉城.单纯疱疹病毒感染与冠心病的关系探讨 [J].国际医药卫生导报,2005,11(24):83-84.
[26] Al-Ghamdi A. Role of herpes simplex virus-1, cytomega-lovirus and Epstein-Barr virus in atherosclerosis [J]. Pak J Pharm Sci,2012,25(1):89-97.
[27] Zhu J, Nieto FJ, Horne BD, et al. Prospective study of pathogen burden and risk of myocardial infarction or death [J]. Circulation, 2001,103(1):45-51.
[28] Raza-Ahmad AKG, Murphy DA, Sullivan JA,et al. Evi-dence of type 2 herpes simplex infection in human coro-nary arteries at the time of coronary artery bypass surgery [J]. Can J Cardiol, 1995,11(11):1025-1029.
[29] Rupprecht HJ, Blankenberg S, Bickel C,et al. Impact of Viral and Bacterial Infectious Burden on Long-Term Prog-nosis in Patients With Coronary Artery Disease [J]. Circu-lation, 2001,104(1):25-31.
[30] Deeks SG, Lewin SR, Havlir DV. The end of AIDS: HIV infection as a chronic disease [J]. The Lancet,2013, 382(9903):1525-1533.
[31] Zerbato JM, Serrao E, Lenzi G,et al. Establishment and Reversal of HIV-1 Latency in Naive and Central Memory CD4 + T Cells In Vitro [J]. J Virol, 2016,90(18):8059-8073.
[32] Ballocca F, D'Ascenzo F, Gili S, et al. Cardiovascular disease in patients with HIV [J]. Europe PMC, 2017,27(8): 558-563.
[33] Baekken M, Os I, Sandvik L,et al. Hypertension in an urban HIV-positive population compared with the general population: influence of combination antiretroviral therapy [J]. J Hypertens, 2008,26(11):2126-2133.
[34] Lang S, Mary-Krause M, Simon A,et al. HIV replica-tion and immune status are independent predictors of the risk of myocardial infarction in HIV- infected individuals [J]. Clin Infect Dis, 2012,55(4):600-607.
[35] Lang S, Marykrause M, Cotte L,et al. Increased risk of myocardial infarction in HIV- infected patients in France, relative to the general population [J]. AIDS, 2010,24(8): 1228-1230.
[36] Choi AI, Li Y, Deeks SG, et al. Association between kidney function and albuminuria with cardiovascular events in HIV-infected persons [J]. Circulation, 2010,121(5):651-658.
[37] Narita M. Classification of Extrapulmonary Manifestations Due to Mycoplasma pneumoniae Infection on the Basis of Possible Pathogenesis [J]. Front Microbiol,2016,7:23.
[38] Bayram A, Erdo?an MB, Ek?i F, et al. Demonstration of Chlamydophila pneumoniae, Mycoplasma pneumoniae, Cy-tomegalovirus, and Epstein- Barr virus in atherosclerotic coronary arteries, nonrheumatic calcific aortic and rheumat-ic stenotic mitral valves by polymerase chain reaction [J]. Anadolu Kardiyol Derg,2011,11(3):237-243.
[39] Mizutani H. Immunologic responses in patients with Myco-plasma pneumoniae infections [J]. Am Rev Respir Dis, 1983,127(2):175-179.
[40] Higuchi ML, Sambiase N, Palomino S,et al. Detection of Mycoplasma pneumoniae and Chlamydia pneumoniae in ruptured atherosclerotic plaques [J]. Braz J Med Biol Res, 2000,33(9):1023-1026.
[41] Roggério A, Sambiase NV, Palomino SA, et al. Correla-tion of bacterial coinfection versus matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 expression in aortic aneurysm and atherosclerosis [J]. Ann Vasc Surg, 2013,27(7):964-971.
[42] 白雪飞,周莹.肺炎支原体感染与冠心病的相关性分析[J].河南医 学研究,2012,21:334-336.
[43] Higuchi ML, Gois JM, Reis MM,et al. Co-infection ra-tios versus inflammation,growth factors and progression of early atheromas [J]. APMIS, 2006,114(5):338-344.
[44] 张会敏,马宏.肺炎支原体致病机制的研究进展[J].中国现代医 生,2015,53(19):157-160.

备注/Memo

备注/Memo:
作者简介:吴晶晶,硕士研究生,研究方向:心血管疾病 共同第一作者:马如超,硕士研究生,研究方向:心血管疾病
通信作者:闫波,E-mail:yanbo@mail.jnmc.edu.cn
更新日期/Last Update: 2018-01-30